A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection BONE MARROW TRANSPL
Insights into the mechanisms underlying aberrant SOX11 oncogene expression in mantle cell lymphoma LEUKEMIA
Intravitreal administration of recombinant human opticin protects against hyperoxia-induced pre-retinal neovascularization EXP EYE RES
Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study LANCET HAEMATOL
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study BRIT J HAEMATOL
Epilepsy progression is associated with cumulative DNA methylation changes in inflammatory genes PROG NEUROBIOL
Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation BONE MARROW TRANSPL